Skip to content
Recall Observatory FDA recall evidence

Drug product

Ketorolac Tromethamine Injection, USP, 60 mg per 2 mL (30 mg per mL), packaged in 2 mL Single Dose Vials (NDC 63323-162-03), 25 x 2 mL Single Dose Vials per tray (NDC 63323-162-02); For IM use only, Not for IV use, Rx only, Fresenius Kabi, Lake Zurich, IL 60047.

D-1297-2020

April 20, 2020

Class II

Product summary

Firm
Fresenius Kabi USA, LLC
Event
Event 85504
Status
Terminated
Classification
Class II
Quantity
3,497,575 vials
Official record key
drug-enforcement:D-1297-2020

Official wording

Reason: Presence of Particulate Matter - found in reserve sample vials at the firm.

Code information: Lot #: 6119229, 6119273, Exp 06/2020; 6119843, Exp 09/2020; 6121115, Exp 02/2021; 6121451, 6121452, 6121496, Exp 03/2021

Distribution pattern: USA Nationwide and Puerto Rico

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    Particulate Matter